ORAMED PHARMACEUTICALS INC.— Sankey Diagram

Annual mode · period ending 2025-12-31 · SEC EDGAR

FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$231M
↑+48.7% +$76Mvs FY2024
Total Liabilities
$31M
↑+213.4% +$21Mvs FY2024
Equity
$200M
↑+36.6% +$53Mvs FY2024
Cash
$46M
↓-15.6% -$8Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
Reconciled values per the annual mode pipeline. Compare against SEC EDGAR filings.
Line itemFY2025FY2024
Total Assets$231M$155M
Current Assets$133M$143M
Cash$46M$54M
ST Investments$5M$3M
Receivables$0$0
Inventory$0$0
Other Current$82M$85M
Non-Current Assets$98M$12M
PPE$586K$698K
Goodwill$0$0
Intangibles$0$0
Investments$8M$4M
Other Non-Current$89M$8M
Total Liab+Eq$200M$146M
Current Liab.$19M$6M
Accounts Payable$443K$789K
Short-Term Debt$0$0
Deferred Revenue$0$0
Other CL$19M$5M
Non-Current Liab.$12M$4M
Long-Term Debt$0$0
Other LT Liab.$12M$4M
Equity$200M$146M
Retained Earnings$123M$177M
Other Equity$76M$0

QuarterCharts · SEC EDGAR data · ORMP · Comparing FY2025 vs FY2024